FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.

Ilya Tsimafeyeu,Alfia Khasanova,Evgenia Stepanova,M. Gordiev,D. Khochenkov,A. Naumova,Ilya Varlamov,Anton Snegovoy,Lev V. Demidov

FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.

2017

Ilya Tsimafeyeu
Alfia Khasanova
Evgenia Stepanova
M. Gordiev
D. Khochenkov
A. Naumova
Ilya Varlamov
Anton Snegovoy
Lev V. Demidov

Background Up to date, there are no data about FGFR2 expression and its predictive role in papillary RCC (pRCC) patients. The aim of the present study was to test FGFR2 expression and mutations for association with survival outcome in patients with pRCC.

Keywords:

Pathology
Immunoenzyme techniques
Neoplasm Grading
Papillary renal cell carcinomas
Survival rate
Medicine
follow up studies
neoplasm staging
survival outcome
overall survival
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations